In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar(Broad Institute), Feng Zhang(Affiliated Hospital of North Sichuan Medical College), Claire Maesner(Harvard University), Erik Wu, Jeffrey J. Widrick(University of Massachusetts Chan Medical School), Amy J. Wagers(Harvard University), Jie Cheng(Northwest A&F University), Kexian Zhu(Harvard University), Wei Leong Chew(Agency for Science, Technology and Research), Le Cong(Stanford Medicine), Winston X. Yan, George M. Church(Harvard University), Rui‐Chun Xiao, F. Ann Ran(Dongfeng General Hospital), Luk H. Vandenberghe(Massachusetts Eye and Ear Infirmary)
DSpace@MIT (Massachusetts Institute of Technology)
January 1, 2016
Cited by 2
Related Papers
Multiplex Genome Engineering Using CRISPR/Cas Systems
|Science|2013|15.9k
Genome engineering using the CRISPR-Cas9 system
|Nature Protocols|2013|11.8k
DNA targeting specificity of RNA-guided Cas9 nucleases
|Nature Biotechnology|2013|5k
In vivo genome editing using Staphylococcus aureus Cas9
|Nature|2015|2.8k